http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120105218-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d9fd632e7ef936d0d33e7b9b5f018c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 |
| filingDate | 2011-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef3f5b337fca315549e5812b9c49705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59068570d4212025ef4a87cdc92b44e |
| publicationDate | 2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120105218-A |
| titleOfInvention | Pharmaceutical composition for the treatment or improvement of allergic rhinitis containing interleukin® 32 inhibitor as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition for treating or ameliorating allergic rhinitis (AR) comprising an interleukin-32 (IL-32) inhibitor and a pharmaceutically acceptable carrier, wherein IL-32 is an allergy. Significantly increased in rhinitis patients, IL-32 inhibitors such as IL-32 antibody, IL-32 antisense, IL-32 siRNA can be usefully used to treat or ameliorate inflammation in allergic rhinitis patients. |
| priorityDate | 2011-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 220.